Hainan Haiyao Co. Hits Day Low of CNY 5.10 Amid Price Pressure

Hainan Haiyao Co., Ltd., a midcap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock declining by 10.05% as of July 17, 2026. The stock reached an intraday low of CNY 5.10, reflecting a challenging trading environment. Over the past year, Hainan Haiyao has underperformed the broader market, generating a return of just 0.99%, compared to the China Shanghai Composite's 16.83%. The company's long-term fundamentals appear weak, with net sales declining at an annual rate of 18.75% over the last five years. Additionally, the operating profit has shown minimal growth at 9.76% during the same period. Despite being net-debt free, Hainan Haiyao's financial metrics indicate a high level of risk, with a debt-equity ratio of 569.30 and a return on equity of -10,384.11%. The stock's performance over various time frames highlights its struggles, including a year-to-date decline of 28.67%. As the company navigates these challenges, its market position remains under scrutiny.